Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
US10849888B2 · kind B2 · utility
2Cited by
85References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 12, 2018 |
| Grant date | Dec 1, 2020 |
| Priority date | — |
| Expiry date | Jul 12, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.